Table 1.
Analysis of all dengue patients with different DENV serotypes
| Demographic Characteristicsa | DENV-1 | DENV-2 | P value | Logistic regression | |
|---|---|---|---|---|---|
| n = 105 | n = 1550 | P value | OR (95% CI) | ||
| Age (Years) | 48 (3–88) | 52 (0–91) | 0.079 | 0.235 | 1.007 |
| 0–59 | 78 (74.3%) | 975 (62.9%) | 0.019 | 0.27 | 1.524 (0.721–3.223) |
| ≥60 | 27 (25.7%) | 575 (37.1%) | |||
| 0–9 | 4 (3.8%) | 50 (3.2%) | 0.011 | 0.104 | |
| 10–19 | 5 (4.8%) | 121 (7.8%) | 1.934 (0.499–7.503) | ||
| 20–29 | 23 (21.9%) | 170 (11.0%) | 0.588 (0.194–1.780) | ||
| 30–39 | 12 (11.4%) | 242 (15.6%) | 1.603 (0.496–5.179) | ||
| 40–49 | 12 (11.4%) | 145 (9.4%) | 1.018 (0.312–3.317) | ||
| 50–59 | 22 (21.0%) | 247 (15.9%) | 0.851 (0.265–2.735) | ||
| 60–69 | 14 (13.3%) | 273 (17.6%) | 1.329 (0.353–5.002) | ||
| ≥70 | 13 (12.4%) | 302 (19.5%) | 1.507 (0.294–7.741) | ||
| Sex | |||||
| Male | 56 (53.3%) | 792 (51.1%) | 0.657 | ||
| Female | 49 (46.7%) | 758 (48.9%) | |||
| Days PSO | 2 (0–8) | 2 (0–22) | 0.879 | ||
| Disease severity | |||||
| Dengue fever | 103 (98.1%) | 1443 (93.1%) | 0.046 | 0.223 | 3.486 (0.469–25.935) |
| Severe dengue | 2 (1.9%) | 107 (6.9%) | |||
| Chronic diseaseb | |||||
| Diabetes mellitus | 6 (5.9%) | 163 (11.1%) | 0.101 | ||
| Hypertension | 15 (14.7%) | 248 (16.8%) | 0.575 | ||
| Congestive heart failure | 3 (2.9%) | 29 (2.0%) | 0.502 | ||
| COPD | 6 (5.9%) | 66 (4.5%) | 0.513 | ||
| Cerebrovascular disease | 3 (2.9%) | 65 (4.4%) | 0.479 | ||
| Moderate to severe CKDc | 2 (2.0%) | 21 (1.4%) | 0.664 | ||
| Charlson comorbidity index scoreb | 1 (0–7) | 1 (0–10) | 0.031 | 0.426 | 1.088 (0.884–1.339) |
| Outcomed | |||||
| Survived | 103 (98.1%) | 1498 (96.9%) | 0.487 | ||
| Death | 2 (1.9%) | 48 (3.1%) | |||
aPresented as the numbers (%) except for average age, days PSO, and CCI score, which are shown as the median (range)
bN = 1,574, DENV-1 = 102, DENV-2 = 1,472. COPD Chronic obstructive pulmonary disease, CKD Chronic kidney disease
cModerate CKD: stage 3A & 3B (GFR 45–59 ml/min & 30–44 ml/min), Severe CKD: stage 4 & 5 (GFR 15–29 ml/min & less than 15 ml/min)
dThere were four patients who did not die from dengue fever in the DENV-2 group and were excluded from the analysis